Anavex Life Sciences
AVXL
AVXL
186 hedge funds and large institutions have $300M invested in Anavex Life Sciences in 2025 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 56 increasing their positions, 50 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.15% more ownership
Funds ownership: 38.06% → 38.21% (+0.15%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1% less capital invested
Capital invested by funds: $302M → $300M (-$1.54M)
Holders
186
Holding in Top 10
1
Calls
$21.1M
Puts
$17.3M
Top Buyers
| 1 | +$3.43M | |
| 2 | +$3.07M | |
| 3 | +$2.24M | |
| 4 |
Jane Street
New York
|
+$2.03M |
| 5 |
BlackRock
New York
|
+$1.89M |
Top Sellers
| 1 | -$8.19M | |
| 2 | -$2.47M | |
| 3 | -$2.26M | |
| 4 |
NL
NWAM LLC
Mercer Island,
Washington
|
-$1.52M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.28M |